# Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)

Study · id `cardio:ct-nct03404063` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03404063](<https://clinicaltrials.gov/study/NCT03404063>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03404063

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT03404063. Randomized; quadruple masking; primary purpose treatment. Start 2017-10-20 (actual); primary completion 2020-07-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT03404063, source copy `cardio:ctgov-nct03404063-2021-04-09`, retrieved 2026-10-26)
- Started: 2017-10-20 (actual) (ClinicalTrials.gov record NCT03404063, source copy `cardio:ctgov-nct03404063-2021-04-09`, retrieved 2026-10-26)
- Primary completion: 2020-07-02 (actual) (ClinicalTrials.gov record NCT03404063, source copy `cardio:ctgov-nct03404063-2021-04-09`, retrieved 2026-10-26)
- Completion: 2021-03-31 (actual) (ClinicalTrials.gov record NCT03404063, source copy `cardio:ctgov-nct03404063-2021-04-09`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT03404063, source copy `cardio:ctgov-nct03404063-2021-04-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03404063-2021-04-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)
- Condition: Myocardial Infarction
- Intervention (Drug): Cardiac Drug
- Intervention (Drug): Placebos
- Lead sponsor: John Paul II Hospital, Krakow
- Lead sponsor class: OTHER
- Collaborator: KCRI
- Collaborator class: OTHER
- Collaborator: National Center for Research and Development, Poland
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: John Paul II Hospital, Krakow (`cardio:org-john-paul-ii-hospital-krakow`)
- Registry lists this organization as a collaborator: National Center for Research and Development, Poland (`cardio:org-national-center-for-research-and-development-poland`)

## Provenance

Content hash: 850629fc0af188799b0cf0e566c864a04667833cfee96fbfad567fdd4b738c24
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
